Alexion Pharmaceuticals to Report Third Quarter 2013 Results on Thursday, October 24, 2013

Alexion Pharmaceuticals to Report Third Quarter 2013 Results on Thursday, October 24, 2013

CHESHIRE, Conn.--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (NAS: ALXN) today announced that the Company will report its financial results for the third quarter ended September 30, 2013 on Thursday, October 24, 2013 before the US financial markets open. Following the release of the financial results, Alexion management will conduct a conference call and audio web cast on Thursday, October 24, 2013, at 10:00 a.m. Eastern Time (ET).


To participate in this conference call, dial 800-289-0438 (USA) or 913-312-0706 (International), passcode 3882932 shortly before 10:00 a.m. ET. A replay of the call will be available from 1:00 p.m. ET through a limited time thereafter. The replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode 3882932. The audio web cast can be accessed at: www.alexionpharma.com.

[ALXN-G]



Alexion Pharmaceuticals, Inc.
Irving Adler, 203-271-8210
Executive Director, Corporate Communications
or
Media:
Alexion Pharmaceuticals, Inc.
Kim Diamond, 203-439-9600
Senior Director, Corporate Communications
or
Investors:
Rx Communications
Rhonda Chiger, 917-322-2569

KEYWORDS:   United States  North America  Connecticut

INDUSTRY KEYWORDS:

The article Alexion Pharmaceuticals to Report Third Quarter 2013 Results on Thursday, October 24, 2013 originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

What is Short Selling?

Make a profit when stocks prices fall.

View Course »

Bonds for Beginners

Learn about fixed income investments.

View Course »

Add a Comment

*0 / 3000 Character Maximum